Curis (CRIS) Gross Margin (2012 - 2025)

Curis (CRIS) reported Gross Margin of 100.0% for Q4 2025, up 51.0% on a YoY basis from 66.23% in Q4 2024, and little changed quarter-over-quarter from 99.53% in Q3 2025.

Curis (CRIS) Gross Margin (2012 - 2025) Analysis & Trends

Curis has reported Gross Margin for 14 years, with the latest figure at 100.0% in Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 51.0% year-over-year to 100.0%; the trailing twelve-month figure through Mar 2026 stood at 99.56% (up 14.0% YoY), and the FY2025 full-year result was 99.52%, up 42.0% from the prior year.
  • Gross Margin for Q4 2025 stood at 100.0%, roughly flat from 99.53% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q4 2025, with the low at 94.93% in Q2 2021.
  • Historically, Gross Margin has averaged 97.82% across 5 years, with a median of 97.94% in 2023.
  • Annual changes were most pronounced in 2022 — Gross Margin jumped 332 bps — and 2023, when it plunged 161 bps.
  • Curis' Gross Margin stood at 96.04% in 2021, then increased by 2 bps to 97.54% in 2022, then increased by 0 bps to 98.0% in 2023, then climbed by 2 bps to 99.49% in 2024, then advanced by 1 bps to 100.0% in 2025.
  • The last three Gross Margin figures came in at 100.0% (Q4 2025), 99.53% (Q3 2025), and 99.42% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 86.85%
9 Abivax 95.45 Bn 95.45 Bn - -
10 Curis 8.58 Mn -6.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 100.00%
Sep 30, 2025 99.53%
Jun 30, 2025 99.42%
Mar 31, 2025 99.41%
Dec 31, 2024 99.49%
Sep 30, 2024 99.25%
Jun 30, 2024 99.53%
Mar 31, 2024 97.75%
Dec 31, 2023 98.00%
Sep 30, 2023 97.88%
Jun 30, 2023 96.63%
Mar 31, 2023 98.96%
Dec 31, 2022 97.54%
Sep 30, 2022 97.81%
Jun 30, 2022 98.24%
Mar 31, 2022 96.01%
Dec 31, 2021 96.04%
Sep 30, 2021 95.03%
Jun 30, 2021 94.93%
Mar 31, 2021 95.02%